Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Certara Teams Up with LabLogic Systems to Speed Up Drug Discovery Analyses

Published: Tuesday, December 17, 2013
Last Updated: Monday, December 16, 2013
Bookmark and Share
Partnership to integrate Certara’s Phoenix WinNonlin PK/PD modelling and non-compartmental analysis product with LabLogic’s Debra LIMS

Certara, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, has partnered with LabLogic Systems to integrate Certara’s Phoenix WinNonlin pharmacokinetic (PK)/pharmacodynamic (PD) modelling and non-compartmental analysis product with LabLogic’s Debra Laboratory Information Management System (LIMS).

Debra is used to manage data from absorption, distribution, metabolism, and excretion (ADME) and protein-binding studies. The resulting solution, allows customers who are using Debra 6 as their LIMS for drug metabolism studies, to push their data directly into Phoenix WinNonlin.

“This integration will allow the two systems to communicate directly, thus removing the need to export data from Debra,” said Dr Daniel Weiner, senior vice president and general manager at Certara. “It will increase system usability and should also provide quality control benefits.”

Debra can manage mass balance, tissue distribution, and PK results from ADME studies. With the addition of LabLogic’s Protein Binding module, Debra can also perform a comprehensive series of protein-binding assays.

Phoenix WinNonlin provides robust, intuitive modelling tools that allow researchers to visualize and analyze their PK and PK/PD data easily. It also enables them to collect all their results, including plots, tables and workflows, in a single project file. This convenient data management approach encourages results sharing and collaboration between team members.

“We developed this integration for Debra and Phoenix WinNonlin, two industry standard drug discovery software products, in direct response to customer requests,” said Huw Loaring, systems director at LabLogic. “We are always looking for ways to help our pharmaceutical customers to streamline their drug discovery process.”

LabLogic is managing customer requests for this product integration.

Certara is dedicated to improving human health by delivering a broad spectrum of software products and consulting services, spanning molecular discovery to clinical development, with special focus on supporting translational approaches to drug development.

LabLogic Systems is a premier instrument and software provider supporting PET/nuclear medicine facilities, pharmaceutical companies, agrochemical research, universities and contract research organizations for over 30 years.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

QPS Implements LabLogic's DEBRA LIMS
Fully validated LIMS now in use in QPS radiolabeled metabolism studies.
Tuesday, September 10, 2013
LabLogic Systems Acquires Southern Scientific
Southern Scientific manufactures and supplies radiation measurement, detection and analytical systems for the nuclear industry, hospitals and research.
Friday, September 09, 2011
LabLogic Strengthens Distributor Network
Professionals in Spain, the Czech Republic and Singapore now have local access to software and instrumentation from LabLogic Systems.
Friday, July 22, 2011
Radiochromatography Systems Assist Cancer Antibody Trials
The Cancer Sciences Division of Southampton University School of Medicine is using radio HPLC and radio TLC systems from LabLogic in the development and quality control of radio-labelled antibody conjugates undergoing clinical trials for treating haematological malignancies.
Tuesday, November 30, 2010
Transatlantic CRO Adopts Common Radio-Labelled ADME Platform
A US/UK contract research laboratory is standardizing on Debra 5.7.8, the latest release of LabLogic’s drug metabolism LIMS.
Monday, August 09, 2010
Drug Metabolism LIMS in Demand for Clinical Studies
LabLogic Systems reports a rapid rise in the number of clinical studies being performed using its drug metabolism LIMS Debra.
Wednesday, June 24, 2009
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Gene Regulation in Brain May Explain Repetitive Behaviors in Rett Syndrome Patients
The research could be a key step in developing treatments to eliminate symptoms that drastically impair the quality of life in Rett patients.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Iron Nanoparticles Make Immune Cells Attack Cancer
Researchers accidentally discover that nanoparticles invented for anemia treatment can trigger the immune system’s ability to destroy tumor cells.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Uncovering Cancer’s ‘Invisibility Cloak’
Researchers discover cancer cell mechanism to become invisible to the body's immune system.
Genetic Impact of Endurance Training
Research has found that endurance training changes genetic activity in thousands of genes, giving rise to large number of altered RNA variants.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!